skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hey everyone, this 1b dollar company looks amazing to me. What am I missing? They have over 300 million in cash and are cash flow positive. This type of drug has been acknowledged recently as part of a drug regime that helps people with lupus nephritis its a calcinurin inhibitor.

How would you value this company? the market doesn’t like it even though it’s making 260million a year going forward with no debt. Is there an issue with the IP?
Read Answer Asked by Mark on May 20, 2025
Q: Hi there, wouldn't it be worthwhile for some to takeover WELL now, by paying a real good premium to todays price and yet... still scoop up WELL on the cheap, based on its future potential and better execution with new management/board?

If so, who do you feel would want to take over WELL?

What would be a good takeover price based on Q1 results and 2025 forward guidance?

Thanks!
Read Answer Asked by Hussein on May 15, 2025
Q: Hi Team,
Over the past several years, as a general rule, one of the best buying opportunities seems to be buying quality, best in breed companies while they are down. Stocks such as NVDA, META, SHOP, BN, CRWD come to mind here where in the past we have seen significant sell offs but the quality names always seem to recover. My question is, are we witnessing this type of opportunity right now with UNH? In reality the name has been a steady eddy, reliable grower in the sector for years. Now...it loses over half it's market cap in a month? In my un-professional opinion this seems much too extreme to me for a company of this magnitude, with a long track record of success, and seemingly huge moat in the US. Is it time to start picking away at buying this name, collecting the now near 3% dividend, and sitting on it for the longer term? Collecting the div and having the name recover in say 3 years would calculate to a quite lucrative return. Thoughts?

Thanks,
Shane.
Read Answer Asked by Shane on May 15, 2025
Q: My focus is on ELV. With the Medicare fraud investigation just announced on UNH, is there the potential for similar risks at ELV? Its stock price seems to have moved down in sympathy with UNH recently (a classic M-pattern technically speaking).

What are your thoughts with a long term investment in this space, and in ELV in particular?
Read Answer Asked by James on May 15, 2025
Q: Bit confused on WELL. In one response, it says it was a solid quarter with no negative comments. Management re-iterated guidance. In another response, issues raised about debt etc and it's rated a hold. Stock shot up in the morning and then gradually declined into a loss. Can you ofer an explanation on what's happening with WELL. Was the quarter encouraging or not.
Read Answer Asked on May 14, 2025
Q: Hi 5i Team - Do you have confidence that the management team can execute on their plans. We have held this stock for some time based on their potential but it doesn't seem to realize this potential. It's performance has been disappointing so am wondering what it would take to get discouraged investors interested again. What are the insider holdings and has there been any recent buying or selling by them. If you think it best to wait until after it reports
tomorrow before answering that's fine. I am considering selling all our shares and using the money elsewhere but want to consider all the factors. Thanks.
Read Answer Asked by Rob on May 14, 2025